Published in Science on September 04, 2003
Primary Prevention of Infection by COVID-19 in Health Providers (PI-Covid-19) | NCT04420260
Evaluation of Silver Nanoparticles for the Prevention of COVID-19 (COVID-19) | NCT04894409
Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol (2005) 9.13
Bats: important reservoir hosts of emerging viruses. Clin Microbiol Rev (2006) 8.77
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci U S A (2005) 8.52
Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet (2009) 4.56
Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci U S A (2006) 4.49
Bats host major mammalian paramyxoviruses. Nat Commun (2012) 4.15
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A (2005) 4.07
Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol (2004) 3.76
Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol (2009) 3.63
H5N1 outbreaks and enzootic influenza. Emerg Infect Dis (2006) 3.49
Identification of a novel coronavirus in bats. J Virol (2005) 3.48
Prediction and prevention of the next pandemic zoonosis. Lancet (2012) 3.44
Prevalence and genetic diversity of coronaviruses in bats from China. J Virol (2006) 3.37
Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci U S A (2005) 3.37
Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus. Emerg Infect Dis (2013) 3.35
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev (2005) 3.18
Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J (2005) 3.14
Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features. J Virol (2006) 3.07
pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol (2004) 3.04
Genomic epidemiology of a dengue virus epidemic in urban Singapore. J Virol (2009) 2.74
Severe acute respiratory syndrome coronavirus phylogeny: toward consensus. J Virol (2004) 2.61
Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J Virol (2009) 2.60
Coronaviruses in bats from Mexico. J Gen Virol (2013) 2.53
Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. MBio (2014) 2.50
The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J Virol (2005) 2.49
Coronavirus HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol (2006) 2.44
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci U S A (2004) 2.38
Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J Virol (2005) 2.35
Antibodies to SARS coronavirus in civets. Emerg Infect Dis (2004) 2.27
Detection of group 1 coronaviruses in bats in North America. Emerg Infect Dis (2007) 2.24
The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol (2009) 2.23
Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice. J Virol (2005) 2.22
Evolutionary insights into the ecology of coronaviruses. J Virol (2007) 2.16
The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol (2013) 2.10
Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation. Proc Natl Acad Sci U S A (2006) 2.07
Comparative analysis of complete genome sequences of three avian coronaviruses reveals a novel group 3c coronavirus. J Virol (2008) 2.06
Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol (2005) 2.05
Detection of novel SARS-like and other coronaviruses in bats from Kenya. Emerg Infect Dis (2009) 2.04
Arbovirus evolution in vivo is constrained by host alternation. Proc Natl Acad Sci U S A (2008) 2.04
Epidemiologic clues to SARS origin in China. Emerg Infect Dis (2004) 2.03
The impact of the SARS epidemic on the utilization of medical services: SARS and the fear of SARS. Am J Public Health (2004) 2.00
Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc Natl Acad Sci U S A (2008) 1.97
A decade after SARS: strategies for controlling emerging coronaviruses. Nat Rev Microbiol (2013) 1.94
Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J Virol (2005) 1.93
Bats are a major natural reservoir for hepaciviruses and pegiviruses. Proc Natl Acad Sci U S A (2013) 1.93
Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. J Virol (2006) 1.91
Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1. J Virol (2006) 1.87
Standards for sequencing viral genomes in the era of high-throughput sequencing. MBio (2014) 1.85
S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol (2004) 1.80
Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants. PLoS Med (2006) 1.78
Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol (2004) 1.78
Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol (2005) 1.76
Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc Natl Acad Sci U S A (2005) 1.75
Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J Virol (2005) 1.75
Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol (2005) 1.73
Systemic spread and propagation of a plant-pathogenic virus in European honeybees, Apis mellifera. MBio (2014) 1.71
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev (2007) 1.68
Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. Proc Natl Acad Sci U S A (2004) 1.66
Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China. Emerg Infect Dis (2004) 1.65
Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev (2015) 1.64
Coronavirus genomics and bioinformatics analysis. Viruses (2010) 1.63
Identification of a severe acute respiratory syndrome coronavirus-like virus in a leaf-nosed bat in Nigeria. MBio (2010) 1.62
Mosaic evolution of the severe acute respiratory syndrome coronavirus. J Virol (2004) 1.61
Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination. J Virol (2011) 1.60
Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol (2006) 1.59
False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. J Clin Microbiol (2004) 1.56
Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants. J Virol (2005) 1.54
Coronavirus antibodies in African bat species. Emerg Infect Dis (2007) 1.54
Coexistence of different genotypes in the same bat and serological characterization of Rousettus bat coronavirus HKU9 belonging to a novel Betacoronavirus subgroup. J Virol (2010) 1.53
Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist. J Virol (2006) 1.53
A novel severe acute respiratory syndrome coronavirus protein, U274, is transported to the cell surface and undergoes endocytosis. J Virol (2004) 1.53
Emerging respiratory viruses: challenges and vaccine strategies. Clin Microbiol Rev (2006) 1.52
Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium. J Virol (2007) 1.52
Wrestling SARS from uncertainty. Emerg Infect Dis (2004) 1.50
Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors. J Virol (2006) 1.49
Summarizing the evidence on the international trade in illegal wildlife. Ecohealth (2010) 1.48
Risk factors for SARS among persons without known contact with SARS patients, Beijing, China. Emerg Infect Dis (2004) 1.48
Detection of a novel and highly divergent coronavirus from asian leopard cats and Chinese ferret badgers in Southern China. J Virol (2007) 1.44
Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol (2011) 1.44
Viral evolution and the emergence of SARS coronavirus. Philos Trans R Soc Lond B Biol Sci (2004) 1.44
Coronaviruses: important emerging human pathogens. J Virol (2014) 1.43
Wildlife as source of zoonotic infections. Emerg Infect Dis (2004) 1.42
Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR. J Clin Microbiol (2004) 1.41
Cynomolgus macaque as an animal model for severe acute respiratory syndrome. PLoS Med (2006) 1.40
Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus. J Virol (2007) 1.39
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial. Vaccine (2008) 1.39
Isolation and characterization of a novel Betacoronavirus subgroup A coronavirus, rabbit coronavirus HKU14, from domestic rabbits. J Virol (2012) 1.39
Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin Diagn Lab Immunol (2004) 1.39
Review of bats and SARS. Emerg Infect Dis (2006) 1.38
Detection and phylogenetic analysis of group 1 coronaviruses in South American bats. Emerg Infect Dis (2008) 1.38
SARS-related virus predating SARS outbreak, Hong Kong. Emerg Infect Dis (2004) 1.38
Emerging pathogens: challenges and successes of molecular diagnostics. J Mol Diagn (2008) 1.38
Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease. J Virol (2015) 1.37
Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol (2011) 1.37
SARS-related perceptions in Hong Kong. Emerg Infect Dis (2005) 1.36
Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet (2003) 24.78
Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science (1998) 19.40
Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature (2004) 16.76
Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet (1998) 16.30
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet (2003) 13.79
Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet (1998) 12.89
Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol (1999) 11.94
Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature (2005) 10.04
Human infection with influenza H9N2. Lancet (1999) 9.73
Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet (2004) 9.36
Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci U S A (2006) 9.26
Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet (2002) 8.70
Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? Proc Natl Acad Sci U S A (1999) 8.62
Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci U S A (2005) 7.12
H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci U S A (2004) 6.61
Cocirculation of avian H9N2 and contemporary "human" H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment? J Virol (2001) 6.45
Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet (2003) 6.23
Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc Natl Acad Sci U S A (2002) 6.17
Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? J Virol (2005) 5.78
The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses. Virology (1985) 5.65
Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci U S A (2000) 5.36
H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J Virol (2000) 5.17
Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol (2005) 5.04
Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med (2000) 4.99
Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science (2010) 4.92
Severe acute respiratory syndrome. Nat Med (2004) 4.75
Involvement of abscisic Acid in potato cold acclimation. Plant Physiol (1983) 4.68
Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis (1999) 4.67
Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation (1997) 4.61
Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci U S A (2006) 4.49
Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology (2002) 4.45
Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res (2005) 4.41
Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virology (2000) 4.37
Potential for transmission of avian influenza viruses to pigs. J Gen Virol (1994) 4.24
Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science (2013) 4.17
Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med (1995) 4.10
Chalcones: an update on cytotoxic and chemoprotective properties. Curr Med Chem (2005) 3.97
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene (2007) 3.96
Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med (2007) 3.75
Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet (2003) 3.66
Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis (2000) 3.63
Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam. Virology (2006) 3.59
An influenza epicentre? Lancet (1982) 3.58
Identification of a novel coronavirus in bats. J Virol (2005) 3.48
Prevalence and genetic diversity of coronaviruses in bats from China. J Virol (2006) 3.37
Characterization of the influenza A virus gene pool in avian species in southern China: was H6N1 a derivative or a precursor of H5N1? J Virol (2000) 3.35
Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis (2002) 3.31
Intestinal inflammatory pseudotumour with regional lymph node involvement: identification of a new bacterium as the aetiological agent. J Pathol (2000) 3.20
Rapid evolution of H5N1 influenza viruses in chickens in Hong Kong. J Virol (1999) 3.20
Isolation and characterization of influenza A viruses from avian species in Hong Kong. Bull World Health Organ (1977) 3.17
Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology (1999) 3.16
Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol (2003) 3.15
The genesis and evolution of H9N2 influenza viruses in poultry from southern China, 2000 to 2005. J Virol (2007) 3.12
Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis (1999) 3.11
Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis (2000) 3.01
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 2.99
Comparison of nasopharyngeal flocked swabs and aspirates for rapid diagnosis of respiratory viruses in children. J Clin Virol (2008) 2.96
Avian influenza in Hong Kong 1997-2002. Avian Dis (2003) 2.90
Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet (2003) 2.84
Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. J Clin Microbiol (2003) 2.77